Details for New Drug Application (NDA): 008565
✉ Email this page to a colleague
NDA 008565 describes THIOSULFIL, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the THIOSULFIL profile page.
The generic ingredient in THIOSULFIL is sulfamethizole. There are four drug master file entries for this compound. Additional details are available on the sulfamethizole profile page.
The generic ingredient in THIOSULFIL is sulfamethizole. There are four drug master file entries for this compound. Additional details are available on the sulfamethizole profile page.
Summary for 008565
| Tradename: | THIOSULFIL |
| Applicant: | Wyeth Ayerst |
| Ingredient: | sulfamethizole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 008565
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
